Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease
Authors:
- 5 February 2019
- journal article
- research article
- Published by Wiley in Cochrane Database of Systematic Reviews
- No. 2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Classical and recent advances in the treatment of inflammatory bowel diseasesBrazilian Journal of Medical and Biological Research, 2015
- Preoperative infliximab use and postoperative complications in Crohn's disease: A systematic review and meta-analysisInternational Journal of Surgery, 2014
- Immunosuppressive therapies for inflammatory bowel diseaseWorld Journal of Gastroenterology, 2014
- Risk of Surgery for Inflammatory Bowel Diseases Has Decreased Over Time: A Systematic Review and Meta-analysis of Population-Based StudiesGastroenterology, 2013
- Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979–2011Gut, 2013
- Anti-tumor necrosis factor and postoperative complications in Crohnʼs disease: systematic review and meta-analysisInflammatory Bowel Diseases, 2012
- Meta‐analysis: effect of preoperative infliximab use on early postoperative complications in patients with ulcerative colitis undergoing abdominal surgeryAlimentary Pharmacology & Therapeutics, 2012
- Current and emerging drugs for the treatment of inflammatory bowel diseaseDrug Design, Development and Therapy, 2011
- Use of Infliximab within 3 Months of Ileocolonic Resection is Associated with Adverse Postoperative Outcomes in Crohn’s PatientsJournal of Gastrointestinal Surgery, 2008
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008